News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,879 Results
Type
Article (8441)
Company Profile (40)
Press Release (270398)
Section
Business (95100)
Career Advice (620)
Deals (17074)
Drug Delivery (12)
Drug Development (25275)
Employer Resources (38)
FDA (4657)
Job Trends (6066)
News (143311)
Policy (9773)
Tag
2024 BioCapital Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (2)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (1)
2026 Biotech Bay Standard (1)
Academia (781)
Adcomms (6)
Allergies (12)
Alliances (18342)
ALS (28)
Alzheimer's disease (352)
Antibody-drug conjugate (ADC) (18)
Approvals (4684)
Artificial intelligence (60)
Autoimmune disease (3)
Automation (3)
Bankruptcy (108)
Best Places to Work (4536)
BIOSECURE Act (1)
Biosimilars (19)
Biotechnology (38)
Bladder cancer (18)
Brain cancer (8)
Breast cancer (60)
Cancer (619)
Cardiovascular disease (36)
Career advice (531)
Career pathing (5)
CAR-T (40)
Cell therapy (137)
Cervical cancer (4)
Clinical research (21103)
Collaboration (209)
Compensation (179)
Complete response letters (2)
COVID-19 (514)
CRISPR (10)
C-suite (97)
Cystic fibrosis (19)
Data (648)
Depression (7)
Diabetes (53)
Diagnostics (2575)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (27)
Drug pricing (8)
Drug shortages (1)
Duchenne muscular dystrophy (15)
Earnings (44118)
Editorial (2)
Employer branding (8)
Employer resources (37)
Events (51620)
Executive appointments (307)
FDA (4969)
Featured Employer (11)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (235)
Gene editing (21)
Generative AI (5)
Gene therapy (57)
GLP-1 (142)
Government (733)
Guidances (17)
Healthcare (7019)
Huntington's disease (1)
IgA nephropathy (5)
Immunology and inflammation (19)
Indications (10)
Infectious disease (533)
Inflammatory bowel disease (33)
Inflation Reduction Act (2)
Influenza (7)
Intellectual property (18)
Interviews (72)
IPO (8646)
IRA (6)
Job creations (1644)
Job search strategy (486)
Kidney cancer (6)
Labor market (9)
Layoffs (139)
Leadership (4)
Legal (2933)
Liver cancer (23)
Lung cancer (94)
Lymphoma (42)
Management (12)
Manufacturing (67)
MASH (26)
Medical device (4955)
Medtech (4956)
Mergers & acquisitions (8660)
Metabolic disorders (141)
Multiple sclerosis (13)
NASH (6)
Neurodegenerative disease (13)
Neuropsychiatric disorders (2)
Neuroscience (474)
NextGen: Class of 2025 (2356)
Non-profit (1492)
Northern California (1153)
Now hiring (15)
Obesity (67)
Opinion (40)
Ovarian cancer (21)
Pain (16)
Pancreatic cancer (25)
Parkinson's disease (32)
Partnered (6)
Patents (32)
Patient recruitment (30)
Peanut (7)
People (28553)
Pharmaceutical (10)
Pharmacy benefit managers (1)
Phase I (6533)
Phase II (9032)
Phase III (7263)
Pipeline (517)
Policy (11)
Postmarket research (805)
Preclinical (2424)
Press Release (66)
Prostate cancer (31)
Psychedelics (5)
Radiopharmaceuticals (125)
Rare diseases (82)
Real estate (2841)
Recruiting (13)
Regulatory (6560)
Reports (15)
Research institute (695)
Resumes & cover letters (88)
Rett syndrome (2)
RSV (1)
Schizophrenia (20)
Series A (41)
Series B (31)
Service/supplier (1)
Sickle cell disease (8)
Southern California (785)
Special edition (1)
Spinal muscular atrophy (32)
Sponsored (4)
Startups (1372)
Stomach cancer (3)
Supply chain (12)
United States (8125)
Vaccines (77)
Venture capitalists (5)
Webinars (4)
Weight loss (24)
Women's health (4)
Worklife (1)
Date
Today (10)
Last 7 days (221)
Last 30 days (985)
Last 365 days (12680)
2025 (2859)
2024 (13606)
2023 (16197)
2022 (21983)
2021 (23472)
2020 (22282)
2019 (17871)
2018 (13627)
2017 (12485)
2016 (11941)
2015 (15455)
2014 (12091)
2013 (9718)
2012 (10456)
2011 (11257)
2010 (10596)
Location
Africa (261)
Alabama (15)
Alaska (2)
Arizona (66)
Arkansas (2)
Asia (14662)
Australia (2160)
California (2302)
Canada (747)
China (112)
Colorado (84)
Connecticut (113)
Delaware (38)
Europe (30049)
Florida (289)
Georgia (39)
Idaho (27)
Illinois (137)
India (6)
Indiana (87)
Iowa (3)
Japan (86)
Kansas (62)
Kentucky (11)
Louisiana (6)
Maine (38)
Maryland (243)
Massachusetts (1648)
Michigan (92)
Minnesota (151)
Mississippi (1)
Missouri (32)
Montana (16)
Nebraska (14)
Nevada (34)
New Hampshire (20)
New Jersey (686)
New Mexico (7)
New York (589)
North Carolina (360)
North Dakota (2)
Northern California (1153)
Ohio (59)
Oklahoma (14)
Oregon (5)
Pennsylvania (378)
Puerto Rico (2)
Rhode Island (11)
South America (470)
South Carolina (10)
Southern California (785)
Tennessee (47)
Texas (259)
Utah (150)
Virginia (51)
Washington D.C. (11)
Washington State (192)
West Virginia (3)
Wisconsin (20)
278,879 Results for "cambrex corporation charles city ia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
December 6, 2024
·
2 min read
Pharm Country
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
Cambrex, a leading global contract development and manufacturing organization, announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
March 18, 2024
·
2 min read
Press Releases
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 11, 2025
·
1 min read
Press Releases
Charles River Announces Agreement with Singapore General Hospital
February 25, 2025
·
3 min read
Press Releases
Cambrex Opens New Stability Storage Facility in Durham, North Carolina
October 17, 2024
·
2 min read
Press Releases
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
December 19, 2024
·
3 min read
Press Releases
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
·
4 min read
Press Releases
Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology
September 19, 2024
·
3 min read
BioCapital
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
Charles River Laboratories International, Inc. announced the publication of its 2023 Corporate Citizenship Report, which includes progress and results from 2022 and 2023.
March 27, 2024
·
5 min read
Pharm Country
Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa
Cambrex announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing.
October 27, 2022
·
2 min read
1 of 27,888
Next
